
Does Medicare Cover IV Infusions?
Original Medicare Part A typically covers the costs if you have an IV infusion during an inpatient hospital stay. If you have an IV infusion on an outpatient basis, Original Medicare Part B can cover eligible expenses. Out-of-pocket costs apply in both cases.
Medicare Advantage plans must cover the same services as Original Medicare, so coverage for IV infusions is the same. However, out-of-pocket expenses may differ.
Does Medicare cover IV infusions?
Original Medicare (parts A and B) and Medicare Advantage (Part C) plans may all cover IV infusions if they're medically essential.
Confirming your hospital status (inpatient or outpatient) with your healthcare team is important, as this can affect how much you pay out of pocket and which Medicare part can cover services.
Original Medicare comprises parts A and B. Part A covers inpatient care, where you experience hospital admission for care. If you receive an IV infusion during your hospital stay, you must pay the 2025 deductible of $1,676 per benefit period. A benefit period starts when you receive a hospital status confirmation as an inpatient and ends when your team discharges you and doesn't provide inpatient care for 60 consecutive days.
Part B covers outpatient care, including overnight hospital stays, so checking your hospital status is vital.
In 2025, the Part B deductible is $257, and you must pay this amount before the plan pays its share of costs toward an IV infusion.
How much does an IV infusion cost?
IV infusions can vary in cost depending on the type of drug or fluid you receive.
If a doctor prescribes a salt treatment, they may use IV sodium chloride. These saline solutions have several medical purposes, including treating dehydration and electrolyte imbalances.
Saline-only IV solutions can be relatively inexpensive, but the costs can increase significantly for IV medications. For example, an initial dose of IV morphine for pain management can cost around $145. In contrast, the current list price for ocrelizumab (Ocrevus), a medication that manages multiple sclerosis (MS), is around $78,000, although people don't usually pay this.
Medicare and at-home infusions
Home infusion therapy means getting IV or subcutaneous drugs or biologicals at home. You need the drug, equipment like a pump, and supplies, such as tubing and cannulas. Nursing services are also necessary so that you or a caregiver can learn how to administer the medications safely.
Medicare Part B covers home infusion equipment and supplies as durable medical equipment (DME). It also covers the required nursing services to teach you how to administer the medications.
You must typically pay 20% of eligible expenses as a coinsurance under Part B.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time Business News
14 hours ago
- Time Business News
How to Reduce Medical Claim Denials
The healthcare industry in the United States is facing a severe crisis. A silent parasite that is putting a strain on both healthcare providers and patients. Both small practices and large hospitals are suffering from it and losing billions of dollars every year. You might be wondering what it is? Well, Insurance Claim Denials. Denials have reached alarming levels, creating administrative burdens that consume valuable resources and delay essential treatments. Recent industry data reveals that providers are spending over $25.7 billion annually just to fight claim denials. However, preventing and resolving the denials is relatively easy if done correctly. In this guide, we will discuss exactly how you can tackle the denials and improve your practice's revenue. So, let's start. Current Stats Behind Claim Denials Like we said above, the healthcare industry is experiencing tons of denials that are not easy to deal with. To give you an idea, let's look at some data. According to Experian Health's report published in 2024, 38% of healthcare providers, including both small practices and large hospitals, report that at least one in ten claims is denied. While some of them are experiencing denial rates exceeding 15%. These are not just denials on paper. It is actual money that you are losing! Imagine 15% revenue just lost because of small mistakes. And guess what? The denials are increasing every year. Recently, 77% of providers reported that denials are increasing compared to just 42% in 2022. Medicare Advantage plans present particular challenges, with research from Health Affairs showing an initial claim denial rate of 17%, though 57% of these denials are ultimately reversed. The financial impact is substantial – providers lose approximately 7% of total dollars initially billed due to claim denials that remain unresolved. Primary Causes of Medical Claim Denials There can be many causes for denials. Human coding error, filing the claims after the deadline, using the wrong modifiers, or just a simple mistake like writing the wrong spellings. So, what can you do about it? Well, before you can resolve the denials, it's necessary to understand the causes of denials. Understanding why claims are denied is the first step toward prevention. Even though there are tens of reasons for denials, all of them can be categorized into the following two categories: Data Quality Issues Missing or inaccurate patient information Incomplete documentation Incorrect coding or billing errors Authorization Issues Missing prior authorization Expired authorizations Services deemed not medically necessary Failing to get prior authorization is one of the biggest challenges. Physicians spend an average of 13 hours per week completing prior authorizations, with 93% reporting that this process delays necessary care. All of this work and hassle can be avoided by implementing the strategies that we are going to discuss in the next section. Proven Strategies to Reduce Claim Denials Eligibility Verification One of the most effective strategies is verifying patient eligibility and benefits before every appointment. This prevents denials due to coverage lapses, plan changes, or incorrect patient information. Automated eligibility verification tools can streamline this process and catch issues before services are rendered. Prior Authorization Workflows We already know that pre-authorization is a headache. To counter it, you can create workflows and checklists. Wondering what to include in your workflows? Here's what we suggest: Creating standardized checklists for different types of services Training staff on payer-specific requirements Implementing automated prior authorization software Establishing clear timelines for submission and follow-up Claims Scrubbing Technology You might not know this yet, but claim scrubbing is an actual thing. And you don't have to do that yourself. There are automated software programs in the market that can do it for you. Automated claims scrubbing tools can identify and correct errors before submission. These systems check for common issues such as missing information, coding errors, and payer-specific requirements. So, even if your billing teams make any errors while filing the claims, the software can detect it and correct them before submitting them to the insurance company. Get RCM Services The simplest and also the most money-friendly way of reducing the claims is to just outsource your billing operations to specialized RCM service providers. Why? These companies have decades of experience in filing claims and managing denials. They charge a minimal amount and deliver amazing results. However, you need to ensure one essential thing before outsourcing. Not all billing companies are good, and generalized billing companies can't help you if you have a specific specialty practice. So, select a billing partner that has expertise in your specific domain. For example. If your healthcare practice deals in gastroenterology, get help from gastroenterology billing service providers, not ENT billers. Wrapping Up That's it! We have tried our best to provide all the information you need to avoid claim denials and prevent them from ever happening. Unfortunately, even with all the precautionary measures, denials will happen. They are simply inevitable. But what you can do is outsource the entire billing operations to specialized billing companies, so you don't have to go through the hassle. TIME BUSINESS NEWS
Yahoo
19 hours ago
- Yahoo
SafeRide Health Ranks No. 358 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies
With Three-Year Revenue Growth of 1,118% Percent, SafeRide is redefining transportation as a trusted care delivery lever for Medicaid and Medicare Advantage plans. NEW YORK, Aug. 12, 2025 /PRNewswire/ -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced that SafeRide Health is ranked No. 358 on the 2025 Inc. 5000 list, placing it among the top 7% of the fastest-growing private companies in America. SafeRide also earned distinctions as No. 5 in the San Antonio metro area, No. 40 in Texas, and No. 41 in the healthcare sector nationally. The Inc. 5000 provides a data-driven snapshot of the most successful companies within the economy's most dynamic segment—independent, entrepreneurial businesses. Past honorees include companies such as Microsoft, Meta, Chobani, Under Armour, Timberland, Oracle, and Patagonia. "We're honored to be named to the Inc. 5000 list, let alone to the top 500," said Robbins Schrader, CEO and Co-Founder of SafeRide Health. "We've built a team that shows up every day for the members of our partner health plans. This recognition is a tribute to their grit, to their hard work, and to the mission we share: fixing healthcare by getting people to care." SafeRide Health's ranking reflects more than just scale; it represents a transformation in how health plans are closing the gap between healthcare need and access. The company delivers more than 10 million rides annually across all 50 states, partnering with leading Medicaid and Medicare Advantage plans to serve members who depend on timely, reliable, and compliant non-emergency medical transportation. Unlike legacy brokers, SafeRide was built from the ground up to solve problems of fragmentation, missed care, and fraud, waste, and abuse (read related case study). It boasts industry-leading performance metrics, including 99% ride fulfillment and grievance rate below 0.25% of rides, and a platform that combines real-time eligibility, smart trip orchestration, and a credentialed national network to turn transportation into a care-experience lever. That people-first approach has earned national recognition, including a 2025 USA Today Top Workplace award as well as Top Workplace awards for Professional Development, Employee Well-Being, Culture Excellence, and Remote Work—affirming SafeRide's culture as a key driver of its growth and operational excellence. This year's Inc. 5000 honorees have demonstrated exceptional growth while navigating economic uncertainty, inflationary pressure, and a fluctuating labor market. Among the top 500 companies on the list, the median three-year revenue growth rate reached 1,552 percent, and those companies have collectively added more than 48,678 jobs to the U.S. economy over the past three years. For the full list, company profiles, and a searchable database by industry and location, visit: "Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company's tenacity and clarity of vision," says Mike Hofman, editor in chief of Inc. "These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn't just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy." Inc. will celebrate the honorees at the 2025 Inc. 5000 Conference & Gala, taking place October 22–24 in Phoenix, and the top 500 will be listed in the Fall issue of Inc. magazine. Methodology Companies on the 2025 Inc. 5000 are ranked according to percentage revenue growth from 2021 to 2024. To qualify, companies must have been founded and generating revenue by March 31, 2021. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2024. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2021 is $100,000; the minimum for 2024 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. About Inc. Inc. is the leading media brand and playbook for the entrepreneurs and business leaders shaping our future. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit About SafeRide HealthSafeRide Health is a technology and services company dedicated to closing the gap between healthcare need and access through modern, scalable non-emergency medical transportation (NEMT). Built for Medicaid and Medicare Advantage populations, SafeRide combines proprietary technology, real-time eligibility, and a nationwide network of credentialed transportation providers to deliver reliable, compliant, and compassionate care access at scale. Trusted by the country's largest payers and provider organizations, SafeRide transforms transportation from a cost center into a strategic lever for outcomes, equity, and member experience. Learn more at Media ContactAshley RobertsSafeRide Health(855) 955-7433mediarelations@ View original content to download multimedia: SOURCE SafeRide Health Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Insider
a day ago
- Business Insider
‘Buy the Dip,' Says Mizuho's Top Analyst About UnitedHealth Stock (UNH)
UnitedHealth Group (UNH) has struggled this year, with shares down about 50% year-to-date. The drop has been driven by rising costs in its Medicare Advantage business, weak Q2 results, a surprise CEO departure, and a federal probe into its billing practices. The latest quarterly miss added to investor concerns. Even so, Mizuho Top analyst Ann Hynes kept her Buy rating, saying the recent weakness could present a buying opportunity for long-term investors. The 4.5-star analyst still sees UnitedHealth as a leader in the managed care industry, but she trimmed her price target to $300 from $350 to reflect a more cautious outlook. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Analyst Views about UNH Stock Hynes noted that UnitedHealth reinstated its 2025 earnings guidance but made important changes to its long-term goals. The company cut Optum Health's margin target to 6–8% from 8–10% and Medicare Advantage margins to 2–4% from 3–5%. It did not reaffirm its prior 13–16% long-term earnings growth goal but also did not withdraw it. The analyst expects pricing pressure and high medical cost trends to continue into 2026. She also flagged underperformance in Optum Health's value-based care and Optum Insight segments. Reflecting these headwinds, she cut her adjusted EPS estimates by 14% for 2025, 20% for 2026, and 24% for 2027. Hynes also warned of potential risks from the expiration of enhanced premium tax credits and upcoming Medicaid changes under the One Big Beautiful Bill Act, which could shift membership and weigh on margins. Nevertheless, she sees UnitedHealth's scale, market position, and diversified business as key strengths, and believes the stock's valuation remains attractive. Is UNH a Good Buy Right Now? average UnitedHealth stock price target implies a 24.62% upside potential.